Vitamin D3 for Life

Live Enlightened

Article

Vitamin D, Vitamin K-Dependent Proteins and Calcium Handling: Full Study

Previous related pageVitamin D in Nutrient Networks: Availability, Metabolism and Biological ResponseNext related pageVitamin D, Vitamin K-Dependent Proteins and Calcium Handling: Study Summary
Study at a glance

How do vitamin D and vitamin K help control calcium?

Vitamin D and vitamin K have different roles in calcium control. Vitamin D helps the body absorb calcium and can increase production of osteocalcin, a protein made by bone-forming cells. Vitamin K supports a chemical change that allows certain proteins to work properly. These include osteocalcin and matrix Gla protein, which helps limit unwanted calcium deposits in soft tissues.

What did laboratory experiments show about vitamins D and K?

In human bone-forming cells grown in the laboratory, vitamin K2 increased the amount of osteocalcin that built up around the cells when active vitamin D was present. Warfarin, which interferes with vitamin K recycling, reduced this effect and mineral formation. This supports a role for vitamin K-dependent protein processing. It does not show that a supplement combination prevents fractures or protects blood vessels in people.

Does vitamin D automatically cause vitamin K deficiency?

The page does not establish this. In a six-month trial in older adults, vitamin D did not significantly change the measured marker of inactive matrix Gla protein overall compared with an inactive treatment. A smaller analysis excluding certain medicine and multivitamin users found a difference, but that result does not establish a general effect in everyone taking vitamin D.

Does everyone taking vitamin D need extra vitamin K?

It is too simple to say that vitamin K sends calcium into bone. Calcium movement also depends on kidneys, hormones, the removal and replacement of bone and other controls. Changes in protein markers do not guarantee stronger bones or less calcium buildup in blood vessels. The evidence does not show that everyone taking vitamin D needs extra vitamin K, or that vitamin K prevents vitamin D toxicity.

Read the full article below ↓

Vitamin D and vitamin K participate in calcium physiology through different mechanisms. Vitamin D contributes strongly to the availability and regulation of calcium, including intestinal absorption and endocrine calcium control. Vitamin K does not replace that role. Instead, it is required for gamma-carboxylation of several vitamin-K-dependent proteins, including osteocalcin in bone and matrix Gla protein in soft tissues and the vasculature. This creates a physiological interaction in which vitamin D can influence the production and calcium-regulatory environment of proteins whose final functional state depends on vitamin K. The relationship belongs within the broader physiology of Vitamin D and Vitamin K and Vitamin D and Calcium Physiology. For a shorter version, see Vitamin D, Vitamin K-Dependent Proteins and Calcium Handling: Study Summary.

Vitamin D changes calcium availability before vitamin K-dependent proteins act

Vitamin D has a classical endocrine role in calcium and phosphate homeostasis. Active vitamin D signalling increases expression of intestinal transport machinery that supports calcium absorption. It also interacts with parathyroid hormone, kidney physiology and bone turnover to help maintain extracellular calcium within a tightly regulated range.

The pathway is developed more broadly in Vitamin D and Calcium Physiology. The important point for the vitamin K interaction is that vitamin D can alter the amount of calcium available to the system and can regulate expression of proteins involved in bone metabolism.

Vitamin D stimulates osteocalcin transcription

Osteoblasts express the vitamin D receptor. Active 1,25-dihydroxyvitamin D can bind VDR, which heterodimerizes with retinoid X receptor and acts through vitamin-D-responsive elements in target genes. Osteocalcin is among the genes whose transcription can be stimulated through this machinery.

This means vitamin D can contribute to production of the osteocalcin protein. But newly synthesised osteocalcin is not automatically in its fully carboxylated state. That post-translational step depends on vitamin K.

The distinction is important because transcription and protein activation are different biological processes. Vitamin D can influence how much protein is produced; vitamin K helps determine whether particular glutamate residues are gamma-carboxylated. This prevents the interaction from being misrepresented as two vitamins doing the same job.

Vitamin K-dependent carboxylation changes calcium-binding behaviour

Vitamin K functions as a cofactor for gamma-glutamyl carboxylase. The carboxylation reaction creates gamma-carboxyglutamate residues within vitamin-K-dependent proteins, changing their capacity to interact with calcium and mineral surfaces.

Osteocalcin is produced by osteoblasts and becomes more strongly associated with mineralised bone when appropriately carboxylated. Matrix Gla protein is expressed in several tissues and is an important inhibitor of inappropriate calcification. Its calcification-inhibitory activity depends in part on vitamin-K-dependent carboxylation.

This creates a functional sequence rather than a slogan about “directing calcium.” Vitamin D influences calcium availability and some protein expression; vitamin K-dependent enzymatic processing changes the functional properties of proteins that participate in mineral handling.

Human osteoblast experiments demonstrate the interaction at protein level

In cultured human osteoblasts, vitamin K₂ enhanced accumulation of osteocalcin in the extracellular matrix when cells were exposed to active vitamin D. The combination increased gamma-carboxyglutamate-containing osteocalcin, while warfarin inhibited the effect and reduced mineralisation.

The experiment is mechanistically useful because warfarin interferes with vitamin K recycling. Blocking that pathway reduced the accumulation of carboxylated osteocalcin and impaired mineralisation in the model, supporting the functional importance of vitamin-K-dependent processing rather than simple coexistence of the two vitamins.

However, an in-vitro osteoblast experiment cannot determine fracture risk, vascular safety or an optimal human supplement combination. It establishes a cellular mechanism that must be interpreted separately from clinical outcomes.

Matrix Gla protein extends the interaction beyond bone

Matrix Gla protein is particularly important because calcium physiology is not only about depositing mineral into bone. Mineralisation also has to be restrained in soft tissues. MGP is one of the endogenous proteins involved in limiting inappropriate vascular calcification.

Vitamin K status affects the carboxylation state of MGP. Dephosphorylated undercarboxylated MGP, often abbreviated dp-ucMGP, is widely used as a marker of poor functional vitamin K status. Higher concentrations indicate more inactive protein in circulation.

This provides the vascular counterpart to osteocalcin biology. Vitamin D influences calcium and mineral physiology, while vitamin K contributes to activation of proteins that interact with mineralisation in different tissue environments. The renal and vascular consequences become particularly relevant in Vitamin D and Kidneys.

The interaction is not proof that vitamin K “sends calcium to bone”

The popular statement that vitamin D puts calcium into the blood and vitamin K sends it into bone is too simple. Calcium movement is governed by intestinal transport, kidney handling, bone turnover, PTH, phosphate, local tissue biology and numerous regulatory proteins. Osteocalcin and MGP participate in that system but do not act as literal directional valves.

Vitamin K-dependent carboxylation changes protein function. That is a more defensible description than saying vitamin K independently decides where calcium goes. The difference matters because oversimplified language can imply a level of control that has not been demonstrated.

Bone and vascular proteins do not have identical functions

Osteocalcin and MGP are both vitamin-K-dependent proteins, but their tissue roles differ. Osteocalcin is associated principally with osteoblast biology and bone matrix. MGP is an important inhibitor of soft-tissue mineralisation. Their common dependence on vitamin K does not make their physiological consequences interchangeable.

This distinction becomes important when interpreting supplementation studies. A treatment may strongly reduce undercarboxylated osteocalcin without producing a large change in bone mineral density. It may reduce dp-ucMGP without slowing established vascular or valvular calcification. Biomarker activation therefore needs to be separated from structural outcome.

Vitamin D supplementation does not automatically create vitamin K deficiency

One hypothesis has been that increasing vitamin-D-driven protein expression could increase demand for vitamin K-dependent carboxylation. Human trial evidence does not establish a universal vitamin-D-induced vitamin K deficiency.

In a randomized six-month vitamin D trial in older adults, vitamin D supplementation did not significantly change dp-ucMGP overall compared with placebo. A restricted analysis excluding users of vitamin K antagonists and multivitamins showed a higher follow-up dp-ucMGP concentration in the vitamin-D group, but this secondary finding does not justify the general claim that vitamin D supplementation depletes vitamin K.

Calcium regulation remains homeostatic rather than supplement-driven

Vitamin D and vitamin K operate inside a calcium-control system that includes PTH, kidney function, phosphate regulation, bone remodelling and degradation of vitamin D metabolites. Their interaction therefore needs to remain anchored to Vitamin D Homeostasis Mechanisms rather than being presented as an isolated two-supplement mechanism.

This is also why excessive vitamin D cannot be made safe simply by adding vitamin K. Vitamin-D-induced hypercalcaemia is driven by excessive calcium availability and signalling and requires its own clinical interpretation. The relevant mechanisms are examined in Vitamin D Toxicity and Hypercalcaemia.

What the mechanistic evidence establishes

The evidence supports a complementary physiological relationship. Vitamin D contributes to calcium absorption, endocrine calcium regulation and expression of proteins including osteocalcin. Vitamin K is required for gamma-carboxylation of osteocalcin, MGP and other vitamin-K-dependent proteins.

The evidence does not establish that vitamin K simply directs all vitamin-D-mobilised calcium into bone, that vitamin K supplementation prevents vitamin D toxicity, or that every person taking vitamin D requires supplemental vitamin K.

The clinical consequences of combining the nutrients are tested separately in Vitamin D and Vitamin K in Calcium Handling, Bone and Vascular Physiology: Evidence Synthesis.

Scientific sources

Transcriptional activation through the vitamin D receptor in osteoblasts. PMID: 9682036.

Vitamin K2 enhances osteocalcin accumulation in the extracellular matrix of human osteoblasts in vitro. PMID: 9076586.

The Importance of Vitamin K and the Combination of Vitamins K and D for Calcium Metabolism and Bone Health: A Review. PMID: 39125301.

Effect of 6-Month Vitamin D Supplementation on Plasma Matrix Gla Protein in Older Adults. PMID: 30678199.

Related reading

Original sources